Literature DB >> 33070963

Crossroad decisions in deep endometriosis treatment options: a qualitative study among patients.

Jeroen Metzemaekers1, Suzanne Slotboom2, Jonathan Sampat3, Polo Vermolen1, Mathilde J G H Smeets4, M Elske van den Akker-van Marle5, Jacques Maas3, Esther C Bakker6, Marjan Nijkamp6, Stephanie Both1, Frank Willem Jansen7.   

Abstract

OBJECTIVE: To study the experiences, considerations, and motivations of patients with endometriosis in the decision-making process for deep endometriosis (DE) treatment options.
DESIGN: Qualitative study using semi-structured in-depth focus group methodology.
SETTING: University medical center. PATIENT(S): A total of 19 Dutch women diagnosed with DE between 27 and 47 years of age. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Focus group topics were disease impact and motives for treatment, expectations of the treatment process, and important factors in the decision process. RESULT(S): Women reported that pain, fertility, and strong fear of complications are important decisive factors in the treatment process. The goal of conceiving a child is considered important, however, sometimes doctors emphasize this topic too much. It emerged that complication counseling is frequently about surgical complications, whereas side effects of hormonal treatments are neglected. Shared decision making and information about treatment options, complications, and side effects are not always optimal, making it difficult to make a well-considered choice. Despite negative experiences encountered after surgery, the positive effect of surgery ensures that most women do not regret their choice. CONCLUSION(S): In the treatment decision process for patients with DE, pain is almost always the most important decisive factor. The wish to conceive and strong fear of complications can change this choice. Doctors should understand the importance of fertility for the majority of women, but, also, if this is not considered paramount, respect that view. To improve shared decision making, exploration of treatment goals, training of healthcare providers, and better patient information provision are desirable.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Decision making; endometriosis; focus groups; qualitative research

Mesh:

Year:  2020        PMID: 33070963     DOI: 10.1016/j.fertnstert.2020.06.041

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  SMURF1-mediated ubiquitylation of SHP-1 promotes cell proliferation and invasion of endometrial stromal cells in endometriosis.

Authors:  Yunmeng Bian; Li Yuan; Xiaoqian Yang; Lichun Weng; Yanli Zhang; He Bai; Jinhong Chen
Journal:  Ann Transl Med       Date:  2021-03

2.  Treatment preferences for medication or surgery in patients with deep endometriosis and bowel involvement - a discrete choice experiment.

Authors:  Jeroen Metzemaekers; M Elske van den Akker-van Marle; Jonathan Sampat; Mathilde J G H Smeets; James English; Elke Thijs; Jacques W M Maas; Frank Willem Jansen; Brigitte Essers
Journal:  BJOG       Date:  2021-12-27       Impact factor: 7.331

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.